Association of detectable cytomegalovirus (CMV) DNA in monocytes rather than positive CMV IgG serology with elevated neopterin levels in community-dwelling older adults

In immunocompetent persons, cytomegalovirus (CMV) is thought to persist primarily in monocytes and myeloid progenitor cells, establishing a chronic infection. In older adults, chronic CMV infection is typically diagnosed by a positive IgG serology. While many studies have shown CMV-specific T-cell expansion in CMV seropositive older individuals, significant heterogeneity has also been observed in this elderly population. In a study of 71 community-dwelling older adults, we assessed CMV viral DNA in peripheral monocytes by nested PCR and compared the relationships of detectable CMV DNA and IgG serology with serum levels of neopterin, a marker for monocyte/macrophage-mediated immune activation. The results showed that 52 (73.2%) participants were CMV seropositive, of whom 30 (57.5%) had detectable CMV DNA. CMV seropositive and seronegative participants did not differ in their neopterin levels, but individuals with detectable CMV DNA had higher neopterin than those without (10.6 ± 4.4 vs 8.0 ± 1.9 nM, respectively, p<.0001) adjusting for demographic and clinical covariates and interferon (IFN)-γ levels. In addition, there was no association between IgG titers and neopterin. These findings suggest that detection of CMV viral DNA in monocytes may be an informative tool to evaluate chronic CMV infection and its potential role in monocyte/macrophage-mediated immune activation in the elderly.

[1]  L. Ferrucci,et al.  Upregulated ex vivo expression of stress-responsive inflammatory pathway genes by LPS-challenged CD14+ monocytes in frail older adults , 2009, Mechanisms of Ageing and Development.

[2]  N. Punjabi,et al.  Serum levels of the immune activation marker neopterin change with age and gender and are modified by race, BMI, and percentage of body fat. , 2010, The journals of gerontology. Series A, Biological sciences and medical sciences.

[3]  B. Johansson,et al.  Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study , 2001, Mechanisms of Ageing and Development.

[4]  B. Johansson,et al.  Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study , 2002, Experimental Gerontology.

[5]  T. Wreghitt,et al.  Cytomegalovirus infection in immunocompetent patients. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  E. Werner,et al.  Value of urinary neopterin in the differential diagnosis of bacterial and viral infections , 1990, Klinische Wochenschrift.

[7]  D. Fuchs,et al.  HMG-CoA Reductase Inhibitors Are Associated with Decreased Serum Neopterin Levels in Stable Coronary Artery Disease , 2003, Clinical chemistry and laboratory medicine.

[8]  M. Cannon,et al.  Use of screening dried blood spots for estimation of prevalence, risk factors, and birth outcomes of congenital cytomegalovirus infection. , 2010, The Journal of pediatrics.

[9]  C. Franceschi,et al.  Massive Load of Functional Effector CD4+ and CD8+ T Cells against Cytomegalovirus in Very Old Subjects1 , 2007, The Journal of Immunology.

[10]  C. Hillyer,et al.  Multicenter evaluation of PCR methods fordetecting CMV DNA in blood donors , 2001, Transfusion.

[11]  G. Pawelec,et al.  Cytomegalovirus and human immunosenescence , 2009, Reviews in medical virology.

[12]  D. Fuchs,et al.  Increasing production of homocysteine and neopterin and degradation of tryptophan with older age. , 2004, Clinical biochemistry.

[13]  G. Pawelec,et al.  Human immunosenescence: is it infectious? , 2005, Immunological reviews.

[14]  D. Fuchs,et al.  Atorvastatin suppresses interferon‐γ‐induced neopterin formation and tryptophan degradation in human peripheral blood mononuclear cells and in monocytic cell lines , 2003, Clinical and experimental immunology.

[15]  S. Leng,et al.  Upregulated monocytic expression of CXC chemokine ligand 10 (CXCL-10) and its relationship with serum interleukin-6 levels in the syndrome of frailty. , 2009, Cytokine.

[16]  J. Sissons,et al.  Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. , 1991, The Journal of general virology.

[17]  Peter N. Murakami,et al.  American Journal of Epidemiology Original Contribution Cytomegalovirus Infection and the Risk of Mortality and Frailty in Older Women: a Prospective Observational Cohort Study , 2022 .

[18]  D. Voehringer,et al.  Age-associated accumulation of CMV-specific CD8+ T cells expressing the inhibitory killer cell lectin-like receptor G1 (KLRG1) , 2003, Experimental Gerontology.

[19]  M. Gore,et al.  Plasma neopterin as an adjunct to C-reactive protein in assessment of infection. , 1991, Clinical chemistry.

[20]  G. Pawelec,et al.  No Immune Risk Profile among individuals who reach 100 years of age: Findings from the Swedish NONA immune longitudinal study , 2007, Experimental Gerontology.

[21]  G. Pawelec,et al.  The immune risk phenotype is associated with IL-6 in the terminal decline stage: Findings from the Swedish NONA immune longitudinal study of very late life functioning , 2006, Mechanisms of Ageing and Development.

[22]  D. Fuchs,et al.  [Neopterin: new immunological marker of autoimmune rheumatic disease]. , 2000, Klinicheskaia meditsina.

[23]  D. Fuchs,et al.  Neopterin as a marker for immune system activation. , 2002, Current drug metabolism.

[24]  P. Moss,et al.  Cytomegalovirus Seropositivity Drives the CD8 T Cell Repertoire Toward Greater Clonality in Healthy Elderly Individuals1 , 2002, The Journal of Immunology.

[25]  J. Sinclair.  Human cytomegalovirus: Latency and reactivation in the myeloid lineage. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[26]  E. Werner,et al.  Neopterin as a marker for activated cell-mediated immunity: application in malignant disease. , 1991, Cancer detection and prevention.

[27]  L. Fried,et al.  Chronic Cytomegalovirus Infection and Inflammation Are Associated with Prevalent Frailty in Community‐Dwelling Older Women , 2005, Journal of the American Geriatrics Society.

[28]  B. Melichar,et al.  Neopterin as an indicator of immune activation and prognosis in patients with gynecological malignancies , 2004, International Journal of Gynecologic Cancer.

[29]  D. Bernstein,et al.  Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection. , 2010, JAMA.

[30]  B. Melichar,et al.  Biochemical profile and survival in nonagenarians. , 2001, Clinical biochemistry.

[31]  J. Dowd,et al.  Socioeconomic disparities in the seroprevalence of cytomegalovirus infection in the US population: NHANES III , 2008, Epidemiology and Infection.

[32]  J. Sissons,et al.  Polymorphonuclear cells are not sites of persistence of human cytomegalovirus in healthy individuals. , 1993, The Journal of general virology.

[33]  S. Peacock,et al.  Severe cytomegalovirus infection in immunocompetent patients. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  E. Werner,et al.  Approach to define “normal aging” in man. Immune function, serum lipids, lipoproteins and neopterin levels , 1988, Mechanisms of Ageing and Development.

[35]  E. Mocarski,et al.  Peripheral blood CD14(+) cells from healthy subjects carry a circular conformation of latent cytomegalovirus genome. , 1999, Blood.

[36]  W. Flanders,et al.  Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  K. Żwirska-Korczala,et al.  Neopterin measurement in clinical diagnosis , 2001, Journal of clinical pharmacy and therapeutics.

[38]  K Bandeen-Roche,et al.  Preclinical mobility disability predicts incident mobility disability in older women. , 2000, The journals of gerontology. Series A, Biological sciences and medical sciences.

[39]  M. Wills,et al.  Latency and reactivation of human cytomegalovirus. , 2002, The Journal of infection.

[40]  D. Fuchs,et al.  Acute cytomegalovirus infections in blood donors are indicated by increased serum neopterin concentrations , 2002, Medical Microbiology and Immunology.